Meta description: A Cairo University trial tests a high power laser acupuncture device for postmenopausal hot flashes, signaling regulatory focus on non drug options.
In regulatory news, Cairo University is sponsoring a prospective device trial to assess the safety and potential effectiveness of high power laser acupuncture for hot flashes in postmenopausal individuals. The study lists three interventions: active device, placebo high power laser acupuncture, and paced respiration exercise as a non device comparator. The trial is not yet recruiting and is led by Cairo University, with details posted on ClinicalTrials.gov under identifier NCT07419542.
What is the trial about?
The study investigates a high power laser acupuncture device as a non drug approach to managing hot flashes in postmenopausal individuals. The aim is to gather safety data and to observe any signals of benefit in hot flash symptoms. The trial design includes three arms: active device using high power laser acupuncture, a sham or placebo high power laser device, and a paced respiration exercise as a non device comparator. The trial is listed with Cairo University as the sponsor and is not yet recruiting according to ClinicalTrials.gov. Details are posted under the identifier NCT07419542 on the ClinicalTrials.gov site.
What is the device and the study design?
The device under study is described as a high power laser acupuncture device. This device is used as a therapeutic modality for hot flashes in the trial. The three arms include an active device, a sham or placebo high power laser device, and a paced respiration exercise arm. The design aims to compare active device performance to placebo control and to a non device intervention. Sponsor Cairo University coordinates the trial, and the record indicates not yet recruiting status.
Why use a placebo high power laser sham?
Sham devices help isolate the device effect from participant expectations and help maintain blinding where feasible.
What are the anticipated safety concerns?
Laser based therapies carry risks such as skin exposure and eye safety. The trial will implement standard safety monitoring and ethics oversight.
Who runs this trial and what is its status?
The sponsor listed is Cairo University, indicating a university level research program. ClinicalTrials.gov shows the study as not yet recruiting as of the report date. The record identifies the trial as a device based intervention with a placebo device and a non device control, aligning with a regulatory driven approach to device testing. The available information does not include results yet.
What are safety and regulatory considerations?
From a regulatory perspective the trial addresses safety and performance of a medical device used to treat hot flashes in a postmenopausal population. The study will require oversight and compliance with good clinical practice for human research. If the device moves toward marketing clearance, regulatory pathways would require evidence of device performance, risk management, and conformity assessment consistent with the applicable framework. The trial’s inclusion of a device arm, a sham device, and a non device control supports evaluation of device related effects in a controlled setting.
What does this mean for patients and clinicians?
If future results show safety and signals of benefit, the device could be considered as an option for managing hot flashes in some patients. Any transition to routine care would require regulatory clearance and robust data on efficacy and safety. Clinicians may monitor this trial to understand how non pharmacologic options compare with non device controls and lifestyle based strategies.
- Q1 What is the purpose of the trial? The trial aims to evaluate a high power laser acupuncture device for hot flashes in postmenopausal individuals using two comparator arms.
- Q2 Who is sponsoring the trial? Cairo University is listed as the sponsor.
- Q3 What is the trial status? The record on ClinicalTrials.gov indicates the study is not yet recruiting.
- Q4 Where can I find more information? See the ClinicalTrials.gov page for NCT07419542 at the link below.
Conclusion
This early stage device trial signals regulatory interest in non drug options for hot flashes. If safety and signals of benefit are demonstrated, future steps would include regulatory clearance and additional studies to confirm efficacy.
Disclaimer: This article is for professionals and does not constitute legal advice. It is not a substitute for regulatory counsel. For legal questions consult qualified counsel.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07419542?term=medical+device